Blood Glucose Control

Metformin, sulfonylureas, and insulin studied in type 2 patients.

Safety and efficacy, adaptive control algorithm to be tested in U.S. and Europe.

Product may offer simpler solution to hypoglycemia over intramuscular injections.

Consider protein intake in addition to counting carbohydrates when calculating insulin doses.

National cohort study examined events in Medicare beneficiaries.

To wrap up this series, we present the final two installments of the conversation between Diabetes in Control Publisher Steve Freed and Dr. Richard Bergman. In part 5, Steve learns more about the institute founded and led by Dr. Bergman at Cedars-Sinai. In part 6, Steve asks what is more important — blood pressure or blood glucose levels?

Diabetes in Control Publisher Steve Freed and Dr. Richard Bergman discuss his ADA presentations — the relationship between diabetes and altitude, and the role of kidneys in diabetes research. Steve also asks why the degredation of insulin in the liver is important in the pathogenesis of diabetes. Dr. Bergman is the founder and director of Diabetes and Obesity Research Institute, Biomedical Sciences at Cedars-Sinai in Los Angeles. He introduced the use of engineering principles to understand the pathogenesis of diabetes.

Nearly half of patients with stable A1c, who do not use insulin, found to be unnecessarily tested three to four times a year.

Safety, efficacy of these new classes of diabetic medication require more detailed investigation.

New study showed women accept disease, implement disease management more easily.